Original article by Tom McIlroy
The Australian Financial Review – Page: 6 : 1-Feb-22

Data from the Productivity Commission shows that screening for bowel, breast and cervical cancer declined at the height of the COVID-19 pandemic, with screening rates down as much as five per cent in high-risk groups. A report released by Cancer Australia in 2021 stated that a decline in cancer testing during the pandemic would increase the likelihood of people being diagnosed with conditions too late to treat or more advanced disease. The Commission’s data was released as part of an annual report on government services across the country, with the report showing that recurrent expenditure on health services by state, territory and federal governments was worth an estimated $122.2 billion in the period covered by the report.

CORPORATES
AUSTRALIA. PRODUCTIVITY COMMISSIONCANCER AUSTRALIA